Flood disaster in Germany: Boehringer Ingelheim increases donation amount to EUR 1 million

Ingelheim,
  • Dramatic situation requires rapid and comprehensive help
  • Donation of EUR 100,000 to the German Red Cross
  • Initial measure with 2,300 meals for Ahrweiler district
© picture alliance/dpa | Thomas Frey
© picture alliance/dpa | Thomas Frey

Ingelheim, July 16, 2021 – Boehringer Ingelheim responds to the dramatic situation in the flooded areas of Rhineland-Palatinate and North Rhine-Westphalia with additional relief measures. The company is increasing the donation amount for emergency aid to EUR 1 million. As part of the fundraising campaign, Boehringer Ingelheim already donated EUR 100,000 to the German Red Cross, which is participating in disaster relief efforts for the affected regions. In addition, the company is in consultation with the authorities to support further relief efforts. In a first step, the company's employee restaurants will supply the affected district of Ahrweiler in Rhineland-Palatinate with 2,300 meals tomorrow, Saturday.

“The images from the affected areas are harrowing,” said Hubertus von Baumbach, Chairman of the Board of Managing Directors. “Our thoughts are with those affected. The tireless efforts of the helpers on the ground give us hope in these difficult times. As a company in the region, we would like to do our utmost to support this help for those affected.”

Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. 

More information about Boehringer Ingelheim can be found at www.boehringer-ingelheim.com 

Media Contacts

Services

Print this Press release

Tags

Press Release Subscription

Sign up here to the Boehringer Ingelheim Newsletter to receive press releases via email.